aTyr Pharma Inc. (LIFE)
aTyr Pharma Statistics
Share Statistics
aTyr Pharma has 69.01M shares outstanding. The number of shares has increased by 0% in one year.
| 69.01M |
| 0% |
| 0% |
| n/a |
| n/a |
| 45,711 |
| 9.5% |
Short Selling Information
| n/a |
| n/a |
| n/a |
| n/a |
Valuation Ratios
The PE ratio is -1.5 and the forward PE ratio is null. aTyr Pharma's PEG ratio is 0.04.
| -1.5 |
| n/a |
| 214.12 |
| n/a |
| 0.83 |
| -2.02 |
| 0.04 |
Enterprise Valuation
aTyr Pharma has an Enterprise Value (EV) of 68.14M.
| 193.02 |
| -1.31 |
| -2.05 |
| -1.82 |
Financial Position
The company has a current ratio of 6.27, with a Debt / Equity ratio of 0.17.
| 6.27 |
| 11.03 |
| 0.17 |
| -0.29 |
| -0.4 |
| 0 |
Financial Efficiency
Return on Equity is -55.58% and Return on Invested Capital is -51.92%.
| -55.58% |
| -41.28% |
| -51.92% |
| $6,303.57 |
| $-899,803.57 |
| 56 |
| 0 |
| -0.04 |
Taxes
| -8K |
| 0.02% |
Stock Price Statistics
The stock price has increased by 18.75% in the last 52 weeks. The beta is 1.19, so aTyr Pharma's price volatility has been higher than the market average.
| 1.19 |
| 18.75% |
| 1.73 |
| 1.59 |
| 39.57 |
| 480,976 |
Income Statement
In the last 12 months, aTyr Pharma had revenue of 353K and earned -50.39M in profits. Earnings per share was -0.94.
| 353K |
| -2.39M |
| -54.92M |
| -50.39M |
| -52.18M |
| n/a |
| -0.94 |
Balance Sheet
The company has 22.54M in cash and 15.1M in debt, giving a net cash position of 7.45M.
| 22.54M |
| 15.1M |
| 7.45M |
| -468.02M |
| 113.25M |
| 80.94M |
Cash Flow
In the last 12 months, operating cash flow was -33.22M and capital expenditures -4.21M, giving a free cash flow of -37.44M.
| -33.22M |
| -4.21M |
| -37.44M |
| -0.7 |
Margins
Gross margin is -676.49%, with operating and profit margins of -15557.79% and -14274.5%.
| -676.49% |
| -15557.79% |
| -14276.77% |
| -14274.5% |
| -14781.3% |
| -15557.79% |
| -10605.1% |
Dividends & Yields
LIFE does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| -66.67% |
| -49.53% |
Analyst Forecast
The average price target for LIFE is $35, which is 1742.1% higher than the current price. The consensus rating is "Buy".
| $35 |
| 1742.1% |
| Buy |
| 1 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Jul 1, 2019. It was a backward split with a ratio of 1:14.
| Jul 1, 2019 |
| backward |
| 1:14 |
Scores
| -4.1 |
| 1 |